Document Detail


From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.
MedLine Citation:
PMID:  22772565     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thus far, the focus of personalized medicine has been the prevention and treatment of conditions that affect adults. Although advances in genetic technology have been applied more frequently to prenatal diagnosis than to fetal treatment, genetic and genomic information is beginning to influence pregnancy management. Recent developments in sequencing the fetal genome combined with progress in understanding fetal physiology using gene expression arrays indicate that we could have the technical capabilities to apply an individualized medicine approach to the fetus. Here I review recent advances in prenatal genetic diagnostics, the challenges associated with these new technologies and how the information derived from them can be used to advance fetal care. Historically, the goal of prenatal diagnosis has been to provide an informed choice to prospective parents. We are now at a point where that goal can and should be expanded to incorporate genetic, genomic and transcriptomic data to develop new approaches to fetal treatment.
Authors:
Diana W Bianchi
Related Documents :
23443605 - Transvaginal sono-guided aspiration of gestational sac concurrent with a local methotre...
22447695 - Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biom...
24363245 - Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura.
23337055 - Frozen embryo transfer: the present practice and beyond.
16750625 - Evaluation of antifungal properties of octyl gallate and its synergy with cinnamaldehyde.
47755 - Amniotic fluid alpha1fetoprotein in the diagnosis of neural tract malformations.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2012-07-06
Journal Detail:
Title:  Nature medicine     Volume:  18     ISSN:  1546-170X     ISO Abbreviation:  Nat. Med.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-09     Completed Date:  2012-09-19     Revised Date:  2012-10-15    
Medline Journal Info:
Nlm Unique ID:  9502015     Medline TA:  Nat Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1041-51     Citation Subset:  IM    
Affiliation:
The Mother Infant Research Institute at Tufts Medical Center and the Division of Genetics, Department of Pediatrics, Floating Hospital for Children, Boston, Massachusetts, USA. dbianchi@tuftsmedicalcenter.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Fetal Diseases / diagnosis*,  genetics,  therapy*
Fetus / metabolism,  pathology*
Genomics / methods*
Humans
Individualized Medicine / methods*
Prenatal Diagnosis / methods*
Transcriptome / genetics
Grant Support
ID/Acronym/Agency:
HD42053-09/HD/NICHD NIH HHS; R01 HD042053/HD/NICHD NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.
Next Document:  IL-23 induces spondyloarthropathy by acting on ROR-?t+ CD3+CD4-CD8- entheseal resident T cells.